Valeo Pharma Croissance future
Future contrôle des critères 2/6
Valeo Pharma is forecast to grow revenue at 20.9% per annum. EPS is expected to grow by 64.2% per annum.
Informations clés
n/a
Taux de croissance des bénéfices
64.2%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 54.4% |
Taux de croissance des recettes | 20.9% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 17 Jun 2024 |
Mises à jour récentes de la croissance future
Recent updates
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost
Jun 14Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower
Apr 20Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing
Mar 02Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump
Jan 17Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%
Jun 08Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%
Jun 24Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts
Jun 17Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?
Feb 08Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
10/31/2025 | 70 | N/A | N/A | N/A | 1 |
10/31/2024 | 58 | N/A | N/A | N/A | 1 |
7/31/2024 | 53 | -32 | -7 | -4 | N/A |
4/30/2024 | 55 | -30 | -10 | -6 | N/A |
1/31/2024 | 54 | -28 | -8 | -3 | N/A |
10/31/2023 | 54 | -28 | -21 | -16 | N/A |
7/31/2023 | 53 | -28 | -20 | -24 | N/A |
4/30/2023 | 45 | -27 | -32 | -25 | N/A |
1/31/2023 | 37 | -26 | -37 | -31 | N/A |
10/31/2022 | 28 | -26 | -35 | -29 | N/A |
7/31/2022 | 18 | -24 | -33 | -20 | N/A |
4/30/2022 | 18 | -22 | -25 | -23 | N/A |
1/31/2022 | 16 | -18 | -22 | -19 | N/A |
10/31/2021 | 14 | -14 | -16 | -12 | N/A |
7/31/2021 | 12 | -9 | -14 | -12 | N/A |
4/30/2021 | 8 | -7 | -10 | -7 | N/A |
1/31/2021 | 8 | -5 | -8 | -6 | N/A |
10/31/2020 | 7 | -5 | -7 | -5 | N/A |
7/31/2020 | 7 | -4 | -5 | -4 | N/A |
4/30/2020 | 8 | -2 | -5 | -4 | N/A |
1/31/2020 | 6 | -4 | -5 | -4 | N/A |
10/31/2019 | 7 | -4 | -3 | -2 | N/A |
7/31/2019 | 7 | -3 | -3 | -2 | N/A |
4/30/2019 | 7 | -3 | -2 | -2 | N/A |
1/31/2019 | 6 | -3 | -2 | -1 | N/A |
10/31/2018 | 4 | -2 | -2 | -1 | N/A |
7/31/2018 | 3 | -3 | -1 | -1 | N/A |
10/31/2017 | 1 | -4 | N/A | -1 | N/A |
10/31/2016 | 1 | -1 | N/A | -2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if VPH's forecast earnings growth is above the savings rate (2.2%).
Bénéfices vs marché: Insufficient data to determine if VPH's earnings are forecast to grow faster than the Canadian market
Croissance élevée des bénéfices: Insufficient data to determine if VPH's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: VPH's revenue (20.9% per year) is forecast to grow faster than the Canadian market (6.9% per year).
Croissance élevée des revenus: VPH's revenue (20.9% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if VPH's Return on Equity is forecast to be high in 3 years time